Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causing the COVID-19 respiratory disease pandemic utilizes unique 2′-<span style="font-variant: small-caps;">O</span>-methyltransferase (2′-O-MTase) capping machinery to camouflage its RNA from innate immune recog...
Main Authors: | José Antonio Encinar, Javier A. Menendez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/5/525 |
Similar Items
-
Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020-11-01) -
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
by: Olujide O. Olubiyi, et al.
Published: (2020-07-01) -
Methylation of Ribosomal RNA: A Mitochondrial Perspective
by: M. Isabel G. Lopez Sanchez, et al.
Published: (2020-07-01) -
Automethylation : a response to enzyme aging
by: Lindquist, Jonathan A.
Published: (2012) -
Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease
by: Candida Manelfi, et al.
Published: (2021-02-01)